4//SEC Filing
Issa Mohamed Khairie 4
Accession 0000879169-25-000068
CIK 0000879169other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:42 PM ET
Size
5.3 KB
Accession
0000879169-25-000068
Insider Transaction Report
Form 4
INCYTE CORPINCY
Issa Mohamed Khairie
EVP, Head of US Oncology
Transactions
- Award
Common Stock
2025-06-30+27,812→ 76,483 total
Footnotes (2)
- [F1]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years from the vesting commencement date of January 6, 2025. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- [F2]Including the June 30, 2025 grant, this includes an aggregate of 76,483 shares of common stock issuable pursuant to previously reported RSUs that have not vested.
Documents
Issuer
INCYTE CORP
CIK 0000879169
Entity typeother
Related Parties
1- filerCIK 0002050035
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 4:42 PM ET
- Size
- 5.3 KB